<http://schema.org/description>
"The FDA wants Regeneron (REGN), Amgen (AMGN) and Pfizer (PFE) to more closely look at their promising cholesterol fighting drugs. That could mean delays, but may not be a deathknell."^^<http://www.w3.org/2001/XMLSchema#string>
<http://www.fool.com/investing/general/2014/03/13/with-fda-concerns-public-whats-next-for-these-chol.aspx?source=eptcnnlnk0000002+>